This article is an erratum on:
Use of Carboxyhemoglobin as an Early Sign of Oxygenator Dysfunction in Patients Supported by Extracorporeal Membrane Oxygenation
Frontiers Production Officeby Cousin, V. L., Giraud, R., Assouline, B., Silva, I. N., and Bendjelid, K. (2022). Front. Med. 9:893642. doi: 10.3389/fmed.2022.893642
An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva.”
The original article has been updated.
Keywords: carboxyhemoglobin, ECMO, critical care, hemolysis, oxygenator clotting
Citation: Frontiers Production Office (2023) Erratum: Use of carboxyhemoglobin as an early sign of oxygenator dysfunction in patients supported by extracorporeal membrane oxygenation. Front. Med. 10:1186498. doi: 10.3389/fmed.2023.1186498
Received: 14 March 2023; Accepted: 14 March 2023;
Published: 24 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn